Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 1Nausea 1Inflammation 1Colorectal Neoplasms 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × ginger extract × Clear all
NCT00064272 2016-10-21

IRB 2003-551

University of Michigan Rogel Cancer Center

Phase 2 Completed
180 enrolled

Nausea, Vomiting

NCT01344538 2016-08-11

Ginger for Colorectal Cancer Prevention

University of Michigan

Phase 2 Completed
30 enrolled 5 charts
Gastrointestinal

Inflammation, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡